908 Devices (MASS) Net Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | -45,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45,958.00 |
| Dec 31, 2025 | 2,268.00 |
| Sep 30, 2025 | 9,479.00 |
| Jun 30, 2025 | 740.00 |
| Mar 31, 2025 | 51,733.00 |
| Dec 31, 2024 | 2,791.00 |
| Sep 30, 2024 | -15,216.00 |
| Jun 30, 2024 | -3,220.00 |
| Mar 31, 2024 | -1,499.00 |
| Dec 31, 2023 | 3,233.00 |
| Sep 30, 2023 | -999.00 |
| Jun 30, 2023 | -435.00 |
| Mar 31, 2023 | -1,929.00 |
| Dec 31, 2022 | -6,222.00 |
| Sep 30, 2022 | 171.00 |
| Jun 30, 2022 | 1,762.00 |
| Mar 31, 2022 | -285.00 |
| Dec 31, 2021 | 15,728.00 |
| Sep 30, 2021 | -1,251.00 |
| Jun 30, 2021 | -10,725.00 |
| Mar 31, 2021 | -3,508.00 |